Integra LifeSciences | IART - Zinsaufwendungen Für Schuld

Aktienkurs
14.10
Täglich Wechseln
-0.40 -2.76%
Monatlich
30.07%
Jährlich
3.91%
Q2 Prognose
13.82




Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
AtriCure USD 1.37M 42K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 149M 4M 2026-03
Boston Scientific USD 90M 0 2026-03
CONMED USD 7.06M 310K 2026-03
Cooper Companies USD 22.4M 2M 2025-12
Dexcom USD 4.2M 500K 2025-12
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 5.44B 5.44B 2026-03
HeartBeam USD 744K 2K 2021-12
Insulet USD 14.7M 5.5M 2026-03
Integra LifeSciences USD 22.46M 1.21M 2026-03
Intuitive Surgical USD 20.11B 58.39B 2026-03
J&J USD 43M 25M 2026-03
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.53M 162K 2026-03
Orthofix International 4.68M 731K 2025-09
Smith & Nephew USD 69M 1000K 2025-12
Stryker USD 46.29B 45.68B 2026-03
Tandem Diabetes Care USD 1.15B 1.15B 2026-03
Teleflex USD 25.72M 2.43M 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03